Eli Lilly and Company
Price Action
Technical Summary
EMERGING TRENDEli Lilly and Company is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 83), indicating clear outperformance against the broad market. Earnings growth of 170% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1155.82 | +6.90% | ABOVE |
| 50 SMA | $1067.00 | +15.80% | ABOVE |
| 100 SMA | $1015.28 | +21.70% | ABOVE |
| 150 SMA | $1027.38 | +20.26% | ABOVE |
| 200 SMA | $989.59 | +24.86% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is LLY in an uptrend right now?
LLY has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is LLY overbought or oversold?
LLY's RSI (14) is 64. The stock is in neutral territory, neither overbought nor oversold.
Is LLY outperforming the market?
LLY has a Relative Strength (RS) Rating of 83 out of 99. Yes, LLY is a market leader, outperforming 83% of all stocks over the past 12 months.
Where is LLY in its 52-week range?
LLY is trading at $1235.56, which is 99% of its 52-week high ($1249.45) and 98% above its 52-week low ($623.78).
How volatile is LLY?
LLY has a Beta of 0.46 and 52-week volatility of 39%. It's less volatile than the S&P 500 - generally more stable.